يعرض 1 - 20 نتائج من 177 نتيجة بحث عن '"КОК"', وقت الاستعلام: 0.60s تنقيح النتائج
  1. 1
    Academic Journal

    المساهمون: The work was financially supported by Sanofi pharmaceutical company, Работа выполнена при финансовой поддержке фармацевтической компании Санофи

    المصدر: Obstetrics, Gynecology and Reproduction; Vol 18, No 2 (2024); 218-230 ; Акушерство, Гинекология и Репродукция; Vol 18, No 2 (2024); 218-230 ; 2500-3194 ; 2313-7347

    وصف الملف: application/pdf

    Relation: https://www.gynecology.su/jour/article/view/2053/1202; Grober U., Schmidt J., Kisters K. Magnesium in prevention and therapy. Nutrients. 2015;7(9):8199–226. doi:10.3390/nu7095388.; Bertinato J., Wu Xiao C., Ratnayake W.M. et al. Lower serum magnesium concentration is associated with diabetes, insulin resistance, and obesity in South Asian and white Canadian women but not men. Food Nutr Res. 2015;59(1):25974. doi:10.3402/fnr.v59.25974.; Al Alawi M.A., Majoni S.W., Falhammar H. Magnesium and human health: perspectives and research directions. Int J Endocrinol. 2018;2018:9041694. doi:10.1155/2018/9041694.; Громова О.А., Торшин И.Ю., Рудаков К.В. и др. Недостаточность магния – достоверный фактор риска коморбидных состояний: результаты крупномасштабного скрининга магниевого статуса в регионах России. Фарматека. 2013;(6):115–29.; Блинов Д.В., Ушакова Т.И., Макацария Н.А. и др. Гормональная контрацепция и дефицит магния: результаты субанализа исследования MAGYN. Акушерство, Гинекология и Репродукция. 2017;11(1):36–48. doi:10.17749/2313-7347.2017.11.1.036-048.; Блинов Д.В., Зимовина У.В., Джобава Э.М. Ведение беременных с дефицитом магния: фармакоэпидемиологическое исследование. ФАРМАКОЭКОНОМИКА. Современная фармакоэкономика и фармакоэпидемиология. 2014;7(2):23–32.; Makatsariya A.D., Bitsadze V.O, Blinov D.V. et al. Pregnant women with symptoms of magnesium deficiency in Russian Federation: MAGIC 2 study results. Magnes Res. 2016;29(3):81. URL: https://www.researchgate.net/publication/316007448_Pregnant_women_with_symptoms_of_magnesium_deficiency_in_Russian_Federation_MAGIC_2_study_results.; Блинов Д.В., Зимовина У.В., Сандакова Е.А., Ушакова Т.И. Дефицит магния у пациенток с гормонально-зависимыми заболеваниями: фармакоэпидемиологический профиль и оценка качества жизни. ФАРМАКОЭКОНОМИКА. Современная фармакоэкономика и фармакоэпидемиология. 2015;8(2):16–24. URL: https://cyberleninka.ru/article/n/defitsit-magniya-u-patsientok-s-gormonalno-zavisimymi-zabolevaniyami-farmakoepidemiologicheskiy-profil-i-otsenka-kachestva-zhizni.; Schimatschek H.F., Rempis R. Prevalence of hypomagnesemia in an unselected German population of 16,000 individuals. Magnes Res. 2001;14(4):283–90.; De Baaij J.H.F., Hoenderop J.G.J., Bindels R.J.M. Magnesium in man: implications for health and disease. Physiol Rev. 2015;95(1):1–46. doi:10.1152/physrev.00012.2014.; Olza J., Aranceta-Bartrina J., González-Gross M. et al. Reported dietary intake, disparity between the reported consumption and the level needed for adequacy and food sources of calcium, phosphorus, magnesium and vitamin D in the Spanish population: findings from the ANIBES study. Nutrients. 2017;9(2):168. doi:10.3390/nu9020168.; Olza J., Aranceta-Bartrina J., González-Gross M. et al. Reported dietary intake and food sources of zinc, selenium, and vitamins A, E and C in the Spanish population: findings from the ANIBES study. Nutrients. 2017;9(7):697. doi:10.3390/nu9070697.; Jahnen-Dechent W., Ketteler M. Magnesium basics. Clin Kidney J. 2012;5(Suppl 1):i3–i14. doi:10.1093/ndtplus/sfr163.; Danziger J., William J.H., Scott D.J. et al. Proton-pump inhibitor use is associated with low serum magnesium concentrations. Kidney Int. 2013;83(4):692–9. doi:10.1038/ki.2012.452.; Наумов Д.Е. Термочувствительные ионные каналы TRPM8 (oбзор литературы). Бюллетень физиологии и патологии дыхания. 2011;(42):89–96.; Громова О.А., Гоголева И.В. Применение магния в зеркале доказательной медицины и фундаментальных исследований в терапии. Дефицит магния и концепция стресса. Трудный пациент. 2007;5(11):29–38.; Voets T., Nilius B., Hoefs S. et al. TRPM6 Forms the Mg 2+ influx channel involved in intestinal and renal Mg 2+ absorption. J Biol Chem. 2004;279(1):19–25. doi:10.1074/jbc.M311201200.; Schlingmann K.P., Gudermann T. A critical role of TRPM channel-kinase for human magnesium transport. J Physiol. 2005;566(Pt 2):301–8. doi:10.1113/jphysiol.2004.080200.; Pilchova I., Klacanova K., Tatarkova Z. et al. The involvement of Mg 2+ in regulation of cellular and mitochondrial functions. Oxid Med Cell Longev. 2017;2017:6797460. doi:10.1155/2017/6797460.; Sontia B., Touyz R.M. Magnesium transport in hypertension. Pathophysiology. 2007;14(3–4):205–11. doi:10.1016/j.pathophys.2007.09.005.; Mutnuri S., Fernandez I., Kochar T. Suppression of parathyroid hormone in a patient with severe magnesium depletion. Case Rep Nephrol. 2016;2016:2608538. doi:10.1155/2016/2608538.; Viering D.H.H.M., de Baaij J.H.F., Walsh S.B. et al. Genetic causes of hypomagnesemia, a clinical overview. Pediatr Nephrol. 2017;32(7):1123–35. doi:10.1007/s00467-016-3416-3.; Seo J.W., Park T.J. Magnesium metabolism. Electrolyte Blood Press. 2008;6(2):86–95. doi:10.5049/EBP.2008.6.2.86.; Pham P.C.T., Pham P.-A.T., Pham S.V. et al. Hypomagnesemia: a clinical perspective. Int J Nephrol Renovasc Dis. 2014;7:219–30. doi:10.2147/IJNRD.S42054.; Lajer H., Daugaard G. Cisplatin and hypomagnesemia. Cancer Treat Rev. 1999;25(1):47–58. doi:10.1053/ctrv.1999.0097.; Bagnis C.I., Deray G. Amphotericin B nephrotoxicity. Saudi J Kidney Dis Transpl. 2002;13(4):481–91.; Lee C.H., Kim G.-H. Electrolyte and acid-base disturbances induced by clacineurin inhibitors. Electrolyte Blood Press. 2007;5(2):126–30. doi:10.5049/EBP.2007.5.2.126.; Sivakumar J. Proton pump inhibitor-induced hypomagnesaemia and hypocalcaemia : case review. Int J Physiol Pathophysiol Pharmacol. 2016;8(4):169–74.; Atsmon J., Dolev E. Drug-induced hypomagnesaemia: scope and management. Drug Saf. 2005;28(9):763–88. doi:10.2165/00002018-200528090-00003.; Makatsariya A.D., Dzhobava E.M., Bitsadze V.O. et al. Observational study of outpatient women in hormone dependent conditions with magnesium deficiency and receiving Magne B6® Forte in Russia (MAGYN Study). Magnes Res. 2016;29(3):82. URL: https://www.researchgate.net/publication/316007423_Observational_study_of_outpatient_women_in_hormone_dependent_conditions_with_magnesium_deficiency_and_receiving_Magne_B6_Forte_in_Russia_MAGYN_Study.; Ryu A., Kim T.H. Premenstrual syndrome : a mini review. Maturitas. 2015;82(4):436–40. doi:10.1016/j.maturitas.2015.08.010.; Rosenstein D.L., Elin R.J., Hosseini J.M. et al. Magnesium measures across the menstrual cycle in premenstrual syndrome. Biol Psychiatry. 1994;35(8):557–61. doi:10.1016/0006-3223(94)90103-1.; Sherwood R.A., Rocks B.F., Stewart A., Saxton R.S. Magnesium and the premenstrual syndrome. Ann Clin Biochem. 1986;23(Pt 6):667–70. doi:10.1177/000456328602300607.; Muneyyirci-Delale O., Nacharaju V.L., Altura B.M., Altura B.T. Sex steroid hormones modulate serum ionized magnesium and calcium levels throughout the menstrual cycle in women. Fertil Steril. 1998;69(5):958–2. doi:10.1016/S0015-0282(98)00053-3.; Tonick S., Muneyyirci-Delale O. Magnesium in women’s health and gynecology. Open J Obstet Gynecol. 2016;6(5):325–33. doi:10.4236/ojog.2016.65041.; Facchinetti F., Sances G., Borella P. et al. Magnesium prophylaxis of menstrual migraine: effects on intracellular magnesium. Headache. 1991;31(5):298–301. doi:10.1111/j.1526-4610.1991.hed3105298.x.; Walker A.F., De Souza M.C., Vickers M.F. et al. Magnesium supplementation alleviates premenstrual symptoms of fluid retention. J Womens Health. 1998;7(9):1157–65. doi:10.1089/jwh.1998.7.1157.; Quaranta S., Buscaglia M.A., Meroni M.G. et al. Pilot study of the efficacy and safety of a modified-release magnesium 250 mg tablet (Sincromag) for the treatment of premenstrual syndrome. Clin Drug Investig. 2007;27(1):51–8. doi:10.2165/00044011-200727010-00004.; De Souza M.C., Walker A.F., Robinson P.A., Bolland K. A synergistic effect of a daily supplement for 1 month of 200 mg magnesium plus 50 mg vitamin B6 for the relief of anxiety-related premenstrual symptoms: a randomized, double-blind, crossover study. J Womens Health Gend Based Med. 2000;9(2):131–9. doi:10.1089/152460900318623.; Fathizadeh N., Ebrahimi E., Valiani M. et al. Evaluating the effect of magnesium and magnesium plus vitamin B6 supplement on the severity of premenstrual syndrome. Iran J Nurs Midwifery Res. 2010;15(Suppl 1):401–5.; Дадак К., Макацария А.Д., Блинов Д.В., Зимовина У.В. Клинические и биохимические аспекты применения препаратов магния в акушерстве, гинекологии и перинатологии. Акушерство, Гинекология и Репродукция. 2014;8(2):69–78.; Черкасова Н.Ю., Фомина А.В., Филиппова О.В. Анализ рынка лекарственных средств для лечения дисменореи. ФАРМАКОЭКОНОМИКА. Современная фармакоэкономика и фармакоэпидемиология. 2013;6(3):36–9.; Унанян А.Л., Алимов В.А., Аракелов С.Э. и др. Фармакоэпидемиология использования оригинального дротаверина при дисменорее: результаты международного многоцентрового исследования. ФАРМАКОЭКОНОМИКА. Современная фармакоэкономика и фармакоэпидемиология. 2014;7(3):44–50.; Оразов М.Р., Чайка А.В., Носенко Е.Н. Купирование хронической тазовой боли, обусловленной аденомиозом, прогестагенами нового поколения. Акушерство, Гинекология и Репродукция. 2014;8(3):6–10.; Джобава Э.М. Вопросы безопасности применения дротаверина в акушерской практике. Акушерство, Гинекология и Репродукция. 2018;12(1):54–60. doi:10.17749/2313-7347.2018.12.1.054-060.; Proctor M.L., Farquhar C.M. Dysmenorrhoea. BMJ Clin Evid. 2007;2007:0813.; Proctor M., Murphy P. A. Herbal and dietary therapies for primary and secondary dysmenorrhoea. Cochrane Database Syst Rev. 2001;(3):CD002124. doi:10.1002/14651858.CD002124.; Seifert B., Wagler P., Dartsch S. et al. Magnesium – a new therapeutic alternative in primary dysmenorrhea. Zentralbl Gynakol. 1989;111(11):755–60. (In German).; Parazzini F., Di Martino M., Pellegrino P. Magnesium in the gynecological practice : a literature review. Magnes Res. 2017;30(1):1–7. doi:10.1684/mrh.2017.0419.; Fontana-Klaiber H., Hogg B. Therapeutic effects of magnesium in dysmenorrhea. Schweiz Rundsch Med Prax. 1990;79(16):491–4. (In German).; Benassi L., Barletta F.P., Baroncini L. et al. Effectiveness of magnesium pidolate in the prophylactic treatment of primary dysmenorrhea. Clin Exp Obstet Gynecol. 1992;19(3):176–9.; Higdon J. An evidence-based approach to vitamins and minerals: health benefits and intake recommendations. Stuttgart, New York: Thieme, 2012. 282 p.; Olatunji L.A., Oyeyipo I.P., Micheal O.S., Soladoye A.O. Effect of dietary magnesium on glucose tolerance and plasma lipid during oral contraceptive administration in female rats. Afr J Med Med Sci. 2008;37(2):135–9.; Akinloye O., Adebayo T.O., Oguntibeju O.O. et al. Effects of contraceptives on serum trace elements, calcium and phosphorus levels. West Indian Med J. 2011;60(3):308–15.; Muneyyirci-Delale O., Nacharaju V.L., Dalloul M. et al. Divalent cations in women with PCOS: implications for cardiovascular disease. Gynecol Endocrinol. 2001;15(3):198–201. doi:10.1080/gye.15.3.198.201.; Sharifi F., Mazloomi S., Hajihosseini R. et al. Serum magnesium concentrations in polycystic ovary syndrome and its association with insulin resistance. Gynecol Endocrinol. 2012;28(1):7–11. doi:10.3109/09513590.2011.579663.; O’Shaughnessy A., Muneyyirci-Delale O., Nacharaju V.L. et al. Circulating divalent cations in asymptomatic ovarian hyperstimulation and in vitro fertilization patients. Gynecol Obstet Invest. 2001;52(4):237–42. doi:10.1159/000052982.; Bird S.T., Hartzema A.G., Brophy J.M. et al. Risk of venous thromboembolism in women with polycystic ovary syndrome: a population-based matched cohort analysis. CMAJ. 2013;185(2):E115–20. doi:10.1503/cmaj.120677.; Громова О.А., Лиманова О.А., Торшин И.Ю. Систематический анализ фундаментальных и клинических исследований указывает на необходимость совместного использования эстроген-содержащих препаратов с препаратами пиридоксина и магния. Акушерство, Гинекология и Репродукция. 2013;7(3):35–50.; Farsinejad-Marj M., Saneei P., Esmaillzadeh A. Dietary magnesium intake, bone mineral density and risk of fracture : a systematic review and meta-analysis. Osteoporos Int. 2016;27(4):1389–99. doi:10.1007/s00198-015-3400-y.; Gur A., Colpan L., Nas K. et al. The role of trace minerals in the pathogenesis of postmenopausal osteoporosis and a new effect of calcitonin. J Bone Miner Metab. 2002;20(1):39–43. doi:10.1007/s774-002-8445-y.; Brodowski J. Levels of ionized magnesium in women with various stages of postmenopausal osteoporosis progression evaluated on the basis of densitometric examinations. Przegl Lek. 2000;57(12):714–6. (In Polish).; Дефицит магния в акушерстве и гинекологии: результаты национального совещания. Акушерство, Гинекология и Репродукция. 2014;8(2):6–10.; Солопова А.Г., Блинов Д.В., Бегович Ё. и др. Неврологические расстройства после гистерэктомии: от патогенеза к клинике. Эпилепсия и пароксизмальные состояния. 2022;14(1):54–64. doi:10.17749/2077-8333/epi.par.con.2022.115.; Блинов Д.В., Солопова А.Г., Плутницкий А.Н. и др. Организация здравоохранения в сфере реабилитации пациенток с онкологическими заболеваниями репродуктивной системы. ФАРМАКОЭКОНОМИКА. Современная фармакоэкономика и фармакоэпидемиология. 2022;15(1):119–30. URL: https://cyberleninka.ru/article/n/organizatsiya-zdravoohraneniya-v-sfere-reabilitatsii-patsientok-s-onkologicheskimi-zabolevaniyami-reproduktivnoy-sistemy.; Блинов Д.В., Солопова А.Г., Ачкасов Е.Е. и др. Медицинская реабилитация пациенток с климактерическим синдромом и хирургической менопаузой: вклад коррекции дефицита магния. ФАРМАКОЭКОНОМИКА. Современная фармакоэкономика и фармакоэпидемиология. 2022;15(4):478–90. doi:10.17749/2070-4909/farmakoekonomika.2022.159.; Блинов Д.В., Солопова А.Г., Ачкасов Е.Е. и др. Роль коррекции дефицита магния в реабилитации женщин с климактерическим синдромом и хирургической менопаузой: результаты исследования MAGYN. Акушерство, Гинекология и Репродукция. 2022;16(6):676–91. doi:10.17749/2313-7347/ob.gyn.rep.2022.371.; Блинов Д.В., Солопова А.Г., Ачкасов Е.Е. и др. Организация реабилитации пациенток с опухолями яичников: современные подходы и будущие направления. ФАРМАКОЭКОНОМИКА. Современная фармакоэкономика и фармакоэпидемиология. 2023;16(2):303–16. URL: https://www.elibrary.ru/ip_restricted.asp?rpage=https%3A%2F%2Fwww%2Eelibrary%2Eru%2Fitem%2Easp%3Fedn%3Ddcaony.; Блинов Д.В., Солопова А.Г., Ачкасов Е.Е. и др. Алгоритм комплексной психотерапевтической поддержки для женщин с психоневрологическими симптомами в период реабилитации после лечения злокачественных новообразований репродуктивной системы. Эпилепсия и пароксизмальные состояния. 2023;15(3):232–45. doi:10.17749/2077-8333/epi.par.con.2023.168.; Магне B6. Инструкция по медицинскому применению. ЛСР-007053/09. Режим доступа: http://www.grls.rosminzdrav.ru. [Дата доступа: 13. 01. 2024].; Магне B6 Форте. Инструкция по медицинскому применению. ЛСР-007053/09. Режим доступа: http://www.grls.rosminzdrav.ru]. [Дата доступа: 13. 01. 2024].; Дижевская Е.В. Мультидисциплинарный подход к коррекции магний-дефицитных состояний. Акушерство, Гинекология и Репродукция. 2015;9(3):68–85.; Дижевская Е.В. Обмен научными данными и экспертными мнениями по фармакотерапии в течение беременности: традиционные и современные подходы III Международный экспертный совет по проблемам дефицита магния в акушерстве и гинекологии. Акушерство, Гинекология и Репродукция. 2015;9(4):93–101.; О Пленуме Президиума Российского общества акушеров-гинекологов. Акушерство и гинекология. 2015;(5):113–5.; Громова О.А. Дефицит магния как проблема современного питания у детей и подростков. Педиатрическая фармакология. 2014;(1):20–30.; Ranade V.V., Somberg J.C. Bioavailability and pharmacokinetics of magnesium after administration of magnesium salts to humans. Am J Ther. 2001;8(5):345–57. doi:10.1097/00045391-200109000-00008.; https://www.gynecology.su/jour/article/view/2053

  2. 2
    Academic Journal
  3. 3
  4. 4
    Academic Journal

    المساهمون: The paper was prepared and submitted with financial support from LLC Primafarm (Russia)., Подготовка и размещение статьи финансировались ООО Примафарм (Россия).

    المصدر: Obstetrics, Gynecology and Reproduction; Vol 17, No 3 (2023); 332-342 ; Акушерство, Гинекология и Репродукция; Vol 17, No 3 (2023); 332-342 ; 2500-3194 ; 2313-7347

    وصف الملف: application/pdf

    Relation: https://www.gynecology.su/jour/article/view/1714/1120; Liao P.V., Dollin J. Half a century of the oral contraceptive pill: historical review and view to the future. Can Fam Physician. 2012;58(12):e757–60.; Regidor P.A. The clinical relevance of progestogens in hormonal contraception: Present status and future developments. Oncotarget. 2018;9(77):34628–38. https://doi.org/10.18632/oncotarget.26015.; Bateson D., Butcher B.E., Donovan C. et al. Risk of venous thromboembolism in women taking the СОСs: A systematic review and meta-analysis. Aust Fam Physician. 2016;45(1):59–64.; De Leo V., Musacchio M.C., Cappelli V. et al. Hormonal contraceptives: pharmacology tailored to women's health. Hum Reprod Update. 2016;22(5):634–46. https://doi.org/10.1093/humupd/dmw016.; Дикке Г.Б. Просто «таблетка». Шестьдесят лет открытий и достижений, которые изменили мир. Часть I. Гормональная контрацепция: от идеи к совершенству. Фарматека. 2019;27(6):38–45. https://doi.org/10.18565/pharmateca.2020.6.10-17.; Fait T., Buryak D., Cirstoiu M.-M. et al. Needs and preferences of women users of oral contraceptives in selected countries in Central and Eastern Europe. Drugs Context. 2018;7:212510. https://doi.org/10.7573/dic.212510.; van Vlijmen E.F., Wiewel-Verschueren S., Monster T.B., Meijer K. Combined oral contraceptives, thrombophilia and the risk of venous thromboembolism: a systematic review and meta-analysis. J Thromb Haemost. 2016;14(7):1393–403. https://doi.org/10.1111/jth.13349.; Morimont L., Haguet H., Dogné J.M. et al. Combined oral contraceptives and venous thromboembolism: Review and perspective to mitigate the risk. Front Endocrinol (Lausanne). 2021;12:769187. https://doi.org/10.3389/fendo.2021.769187.; Михайлова О.И., Мирзабекова Д.Д., Тютюнник В.Л., Кан Н.Е. Выбор метода контрацепции в послеродовом периоде. Зарождение жизни. 2022;(1):40–4. https://doi.org/10.46393/27826384_2022_1_40.; Guang-Sheng F., Mei-Lu B., Li-Nan C. et al. Efficacy and safety of the combined oral contraceptive ethinylestradiol/drospirenone (Yasmin) in healthy Chinese women: a randomized, open-label, controlled, multicentre trial. Clin Drug Investig. 2010;30(6):387–96. https://doi.org/10.1007/BF03256908.; Caprio M., Antelmi A., Chetrite G. et al. Antiadipogenic effects of the mineralocorticoid receptor antagonist drospirenone: potential implications for the treatment of metabolic syndrome. Endocrinology. 2011;152(1):113–25. https://doi.org/10.1210/en.2010-0674.; Wallwiener C.W., Wallwiener L.-M., Seeger H. et al. Prevalence of sexual dysfunction and impact of contraception in female German medical students. J Sex Med. 2010;7(6):2139–48. https://doi.org/10.1111/j.1743-6109.2010.01742.x.; Higgins J.A., Hoffman S., Graham S.A., Sanders S.A. Relationships between condoms, hormonal methods, and sexual pleasure and satisfaction: an exploratory analysis from the Women's Well-Being and Sexuality Study. Sex Health. 2008;5(4):321–3. https://doi.org/10.1071/sh08021.; Здравомыслов В.И., Анисимова З.Е., Либих С.С. Функциональная женская сексопатология. Пермь: ТОО фирма «Репринт», 1994. 272 с.; Sanders S.A., Graham C.A, Bass J.L., Bancroft J. A prospective study of the effects of oral contraceptives on sexuality and well-being and their relationship to discontinuation. Contraception. 2001;64(1):51–8. https://doi.org/10.1016/s0010-7824(01)00218-9.; Shamseddin M., De Martino F., Constantin C. et al. Contraceptive progestins with androgenic properties stimulate breast epithelial cell proliferation. EMBO Mol Med. 2021;13(7):e14314. https://doi.org/10.15252/emmm.202114314.; Мусина Е.В., Коган И.Ю., Тарасова М.А. Лечебное действие дезогестрела при масталгии у женщин с фиброзно-кистозной болезнью молочных желез. Проблемы репродукции. 2013;(5):42–6.; Жуковская И.Г., Хузина Л.Ф. Некоторые аспекты приверженности к комбинированной гормональной контрацепции у молодых женщин. Медицинский совет. 2022;16(16):93–8. https://doi.org/10.21518/2079-701X-2022-16-16-93-98.; Ebede T.L., Arch E.L., Berson D. Hormonal treatment of acne in women. J Clin Aesthet Dermatol. 2009;2(12):16–22.; Mueck A.O., Sitruk-Ware R. Nomegestrol acetate, a novel progestogen for oral contraception. Steroids. 2011;76(6):531–9. https://doi.org/10.1016/j.steroids.2011.02.002.; Nappi R.E., Albani F., Tonani S. et al. Psychosexual well-being in women using oral contraceptives containing drospirenone. Funct Neurol. 2009;24(2):71–5.; Ndefo U.A., Eaton A., Green M.R. Polycystic ovary syndrome: a review of treatment options with a focus on pharmacological approaches. P T. 2013;38(6):336–55.; Amiri M., Kabir A., Nahidi F. et al. Effects of combined oral contraceptives on the clinical and biochemical parameters of hyperandrogenism in patients with polycystic ovary syndrome: a systematic review and meta-analysis. Eur J Contracept Reprod Health Care. 2018;23(1):64–77. https://doi.org/10.1080/13625187.2018.1435779.; Ehrhart-Bornstein M., Lamounier-Zepter V., Schraven A. et al. Human adipocytes secrete mineralcorticoid-releasing factors. Proc Natl Acad Sci USA. 2003;100(24):14211–6. https://doi.org/10.1073/pnas.2336140100.; Bird S.T., Hartzema A.G., Brophy J.M et al. Risk of venous thromboembolism in women with polycystic ovary syndrome: a population-based matched cohort analysis. CMAJ. 2013;185(2):E115–20. https://doi.org/10.1503/cmaj.120677.; Dinger J.C., Heinemann L.A.J., Kühl-Habich D. The safety of a drosperinone-containing oral contraceptive: final results from the European Active Surveillance study on oral contraceptives based on 142,475 women-years of observation. Contraception. 2007;75(5):344–54. https://doi.org/10.1016/j.contraception.2006.12.019.; https://www.gynecology.su/jour/article/view/1714

  5. 5
    Academic Journal
  6. 6
    Academic Journal

    المؤلفون: G. B. Dikke, Г. Б. Дикке

    المصدر: Obstetrics, Gynecology and Reproduction; Vol 16, No 3 (2022); 244-254 ; Акушерство, Гинекология и Репродукция; Vol 16, No 3 (2022); 244-254 ; 2500-3194 ; 2313-7347

    وصف الملف: application/pdf

    Relation: https://www.gynecology.su/jour/article/view/1349/1020; Schindler A.E., Campagnoli C., Druckmann R. et al. Classification and pharmacology of progestins. Maturitas. 2008;61(1):171–80. https://doi.org/10.1016/j.maturitas.2003.09.014.; Kulier R., Helmerhorst F.M., Maitra N., Gülmezoglu A.M. Effectiveness and acceptability of progestogens in combined oral contraceptives – a systematic review. Reprod Health. 2004;1(1):1–9. https://doi.org/10.1186/1742-4755-1-1.; Hooper D.J. Attitudes, awareness, compliance and preferences among hormonal contraception users: a global, cross-sectional, selfadministered, online survey. Clin Drug Investig. 2010;30(11):749–63. https://doi.org/10.2165/11538900-000000000-00000.; Прилепская В.Н., Назарова Н.М., Тарасова М.А., Летуновская А.Б. Международный проект «CHOICE»: краткий обзор результатов исследования. Гинекология. 2010;12(4):26–8.; Жук С.И., Захурдаева Л.Д. Особенности современного консультирования по вопросам контрацепции. Медицинские аспекты здоровья женщины. 2011;(4):29–32.; Moreau C., Cleland K., Trussell J. Contraceptive discontinuation attributed to method dissatisfaction in the United States. Contraception. 2007;76(4):267–72. https://doi.org/10.1016/j.contraception.2007.06.008.; Fait T., Buryak D., Cirstoiu M.-M. et al. Needs and preferences of women users of oral contraceptives in selected countries in Central and Eastern Europe. Drugs Context. 2018;7:212510. https://doi.org/10.7573/dic.212510.; Bahamondes L., Pinho F., de Melo N.R. et al. Associated factors with discontinuation use of combined oral contraceptives. Rev Bras Ginecol Obstet. 2011;33(6):303–9. [Article in Portuguese]. https://doi.org/10.1590/s0100-72032011000600007.; Пустотина О.А., Герейбекова Э.Р. Побочные эффекты современных комбинированных оральных контрацептивов. Акушерство и гинекология. Новости. Мнения. Обучение. 2016;(3):96–102.; Мынко О.И., Ашрафзянова Д.Р., Лобанова В.В. Комбинированные оральные контрацептивы: частота применения и возникновения побочных эффектов у женщин репродуктивного возраста. ЭНИГМА. 2020;(26):105–14.; Mack N., Crawford T.J., Guise J.M. et al. Strategies to improve adherence and continuation of shorter-term hormonal methods of contraception. Cochrane Database Syst Rev. 2019;4(4):CD004317. https://doi.org/10.1002/14651858.CD004317.pub5.; Poindexter A. The emerging use of the 20-microg oral contraceptive. Fertil Steril. 2001;75(3):457–6. https://doi.org/10.1016/s0015-0282(00)01747-7.; Edelman A., Micks E., Gallo M.F. et al. Continuous or extended cycle vs. cyclic use of combined hormonal contraceptives for contraception. Cochrane Database Syst Rev. 2014;2014(7):CD004695. https://doi.org/10.1002/14651858.CD004695.pub3.; Gallo M.F., Nanda K., Grimes D.A. et al. 20 µg versus >20 µg estrogen combined oral contraceptives for contraception. Cochrane Database Syst Rev. 2013;2013(8):CD003989. https://doi.org/10.1002/14651858.CD003989.pub5.; Carr B.R. Cycle control with desogestrel-containing oral contraceptives comparison of a monophasic and triphasic regimen. Int J Fertil Menopausal Stud. 1993;38(5):274–9.; Darney P. Safety and efficacy of a triphasic oral contraceptive containing desogestrel: results of three multicenter trials. Contraception. 1993;48(4):323–37. https://doi.org/10.1016/0010-7824(93)90078-l.; Ferguson H., Vree M.L., Wilpshaar J., Eskes T.K. Multicenter study of the efficacy, cycle control and tolerability of a phasic desogestrel-containing oral contraceptive. Eur J Contracept Reprod Health Care. 2000;5(1):35– 45. https://doi.org/10.1080/13625180008500378.; Coenen C.M., Thomas C.M., Borm G.F. et al. Changes in androgens during treatment with four low-dose contraceptives. Contraception. 1996;53(3):171–6. https://doi.org/10.1016/0010-7824(96)00006-6.; Katz H.I., Kempers S., Akin M.D. et al. Effect of a desogestrel-containing oral contraceptive on the skin. Eur J ContraceptReprod Health Care. 2000;5(4):248–55. https://doi.org/10.1080/13625180008500411.; Prilepskaya V.N., Serov V.N., Zharov E.V. et al. Effects of a phasic oral contraceptive containing desogestrel on facial seborrhea and acne. Contraception. 2003;68(4):239–45. https://doi.org/10.1016/s0010-7824(03)00167-7.; Kränzlin H.T., Nap M.A. The effect of a phasic oral contraceptive containing Desogestrel on seborrhea and acne. Eur J Contracept Reprod Health Care. 2006;11(1):6–13. https://doi.org/10.1080/13625180500252638.; Vartiainen M., de Gezelle H., Broekmeulen C.J. Comparison of the effect on acne with a combiphasicdesogestrel-containing oral contraceptive and a preparation containing cyproterone acetate. Eur J Contracept Reprod Health Care. 2001;6(1):46–53.; van Vloten W.A., van Haselen C.W., van Zuuren E.J. et al. The effect of 2 combined oral Contraceptives containing either drospirenone or cyproterone acetate on acne and seborrhea. Cutis. 2002;69(4 Suppl):2–15.; De Leo V., Di Sabatino A., Musacchio M.C. et al. Effect of oral contraceptives on markers of hyperandrogenism and SHBG in women with polycystic ovary syndrome. Contraception. 2010;82(3):276–80. https://doi.org/10.1016/j.contraception.2010.04.002.; van Vliet H.A., Grimes D.A., Lopez L.M. et al. Triphasic versus monophasic oral contraceptives for contraception. Cochrane Database Syst Rev. 2011; 2011(11):CD003553. https://doi.org/10.1002/14651858.CD003553.pub2.; American College of Obstetricians and Gynecologists’ Committee on Health Care for Underserved Women, Contraceptive Equity Expert Work Group, and Committee on Ethic. Patient-Centered Contraceptive Counseling. ACOG Committee Statement Number 1. Obstet Gynecol. 2022;139(2):350–3. https://doi.org/10.1097/AOG.0000000000004659.; Dinger J., Bardenheuer K., Heinemann K. Cardiovascular and general safety of a 24-day regimen of drospirenone-containing combined oral contraceptives: final results from the International Active Surveillance Study of Women Taking Oral Contraceptives. Contraception. 2014;89(4):253–63. https://doi.org/10.1016/j.contraception.2014.01.023.; Kashanian M., Shahpourian F., Zare O. A comparison between monophasic levonorgestrel-ethinyl estradiol 150/30 and triphasic levonorgestrel-ethinyl estradiol 50-75-125/30-40-30 contraceptive pills for side effects and patient satisfaction: a study in Iran. Eur J Obstet Gynecol Reprod Biol. 2010;150(1):47–51. https://doi.org/10.1016/j.ejogrb.2010.01.010.; Roumen F.J. Review of the combined contraceptive vaginal ring, NuvaRing. Ther Clin Risk Manag. 2008;4(2):441–51. https://doi.org/10.2147/tcrm.s1964.; Lawrie T.A., Helmerhorst F.M., Maitra N.K. et al. Types of progestogens in combined oral contraception: effectiveness and side-effects. Cochrane Database Syst Rev. 2011;(5):CD004861. https://doi.org/10.1002/14651858.CD004861.pub2.; Grossman BN. Managing adverse effects of hormonal contraceptives. Am Fam Physician. 2010;82(12):1499–506.; Foran T. The management of irregular bleeding in women using contraception. Aust Fam Physician. 2017;46(10):717–20.; Oral contraceptive-related uterine bleeding management. Family Practice Notebook. Available at: https://fpnotebook.com/Gyn/Pharm/OrlCntrcptvRltdUtrnBldngMngmnt.htm.; Vree M.L., Schmidt J. A large observational clinical evaluation of a desogestrel-containing combiphasic oral contraceptive in Germany. Eur J Contracept Reprod Health Care. 2001;6(2):108–14.; Дикке Г.Б. Пять шагов к успешной контрацепции. Руководство для врачей. М., 2017. 428 с.; Кузнецова И.В. Метаболические эффекты комбинированной гормональной контрацепции и риск тромботических осложнений. Акушерство и гинекология. 2016;(6):108–14. https://doi.org/10.18565/aig.2016.6.108-114.; Baerwald A.R., Pierson R.A. Ovarian follicular development during the use of oral contraception: a review. J Obstet Gynaecol Can. 2004;26(1):19–24. https://doi.org/10.1016/s1701-2163(16)30692-2/; Bastianelli C., Farris M., Rosato E. et al. Pharmacodynamics of combined estrogen-progestin oral contraceptives: 1. Effects on metabolism. Expert Rev Clin Pharmacol. 2017;10(3):315–26. https://doi.org/10.1080/17512433.2017.1271708.; Lobo R.A., Skinner J.B., Lippman J.S., Cirillo S.J. Plasma lipids and desogestrel and ethinyl estradiol: a meta-analysis. Fertil Steril. 1996;65(6):1100–9.; Silva-Bermudez L.S., Toloza F.J.K., Perez-Matos M.C. et al. Effects of oral contraceptives on metabolic parameters in adult premenopausal women: a meta-analysis. Endocr Connect. 2020;9(10):978–98. https://doi.org/10.1530/EC-20-0423.; Godsland I.F., Walton C., Felton C. et al. Insulin resistance, secretion, and metabolism in users of oral contraceptives. J Clin Endocrinol Metab. 1992;74(1):6470. https://doi.org/10.1210/jcem.74.1.1530790.; Gaspard U., Endrikat J., Desager J.P. et al. A randomized study on the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on lipid and lipoprotein metabolism over a period of 13 cycles. Contraception. 2004;69(4):271–8. https://doi.org/10.1016/j.contraception.2003.11.003.; Adeyanju O.A., Olatunji L.A. Drospirenone-containing oral contraceptives do not affect glucose regulation and circulating corticosterone. J Bas Clinic Physiol Pharm. 2019;30(5):20180184. https://doi.org/10.1515/jbcpp-2018-0184.; Радзинский В.Е., Хамошина М.Б., Абдуллаева Р.Г., Лебедева М.Г. Гормональная контрацепция – лечение и профилактика репродуктивных нарушений у девушек-подростков. Доктор.Ру. 2008;(6):54–8.; https://www.gynecology.su/jour/article/view/1349

  7. 7
    Academic Journal

    المصدر: Obstetrics, Gynecology and Reproduction; Vol 15, No 6 (2021); 777-787 ; Акушерство, Гинекология и Репродукция; Vol 15, No 6 (2021); 777-787 ; 2500-3194 ; 2313-7347

    وصف الملف: application/pdf

    Relation: https://www.gynecology.su/jour/article/view/1188/977; Петров Ю.А., Шаталов А.Е., Купина А.Д. Гормональная контрацепция: безопасность и переносимость. Медико-фармацевтический журнал Пульс. 2019;21(9):37–43. https://doi.org/10.26787/nydha-2686-6838-2019-21-9-37-43.; Ледина А.В., Короленкова Л.Н., Ледин Е.В. Онкологические риски и польза гормональной контрацепции: литературный обзор и практические вопросы. Гинекология. 2019;21(1):75–9. https://doi.org/10.26442/20795696.2019.1.190272.; Руководство по контрацепции. Под ред. проф. В.Н. Прилепской. 4-е изд. М.: МЕДпресс-информ, 2017. 464 с.; Прилепская В.Н., Абакарова П.Р., Яроцкая Е.Л. Современная контрацепция и качество жизни женщины. Доктор.Ру. 2017;(3):37–42.; Подзолкова Н.М., Колода Ю.А., Роговская С.И., Коренная В.В. Современная контрацепция: новые возможности, критерии безопасности, основы консультирования. М.: ГЭОТАР-Медиа, 2019. 117 с.; Доброхотова Ю.Э., Боровкова Е.И. Персонализированный подход к выбору контрацептива: взвешиваем все за и против. Гинекология. 2017;19(3):40–4.; Тихомиров А.Л., Юдина Т.А., Бурчаков Д.И. Комбинированные оральные контрацептивы в аспектах повышения качества жизни молодых женщин. Медицинский алфавит. 2019;1(1):15–18. https://doi.org/10.33667/2078-5631-2019-1-1(376)-15-18.; Унанян А.Л., Никонец А.Д., Аминова Л.Н. и др. Неконтрацептивные эффекты комбинированных оральных контрацептивов: преимущества и риски применения. Гинекология. 2017;19(2):69–74.; Farris M., Bastianelli C., Rosato E. et al. Pharmacodynamics of combined estrogen-progestin oral contraceptives: 2 effects on hemostasis. Exp Rev Clin Pharmacol. 2017;10(10):1129–44. https://doi.org/10.1080/17512433.2017.1356718.; Медицинские критерии приемлемости для использования методов контрацепции, 5-е издание. ВОЗ, 2015. 192 c. Режим доступа: https://www.euro.who.int/__data/assets/pdf_file/0005/348116/MEC-merged.pdf.; Макацария А.Д., Бицадзе В.О., Акиньшина С.В. Тромбозы и тромбоэмболии в акушерско-гинекологической клинике: Молекулярно-генетические механизмы и стратегия профилактики тромбоэмболических осложнений: Руководство для врачей. М.: МИА, 2007. 1064 с.; Serfaty D. Update on the contraceptive contraindications. J Gynecol Obstet Hum Reprod. 2019;48(5):297–307. https://doi.org/10.1016/j.jogoh.2019.02.006.; Sitruk-Ware R. Hormonal contraception and thrombosis. Fertil Steril. 2016;106(6):1289–94. https://doi.org/10.1016/j.fertnstert.2016.08.039.; Plu-Bureau G., Maitrot-Mantelet L., Hugon-Rodin J. et al. Hormonal contraceptives and venous thromboembolism: an epidemiological update. Best Pract Res Clin Endocrinol Metab. 2013;27(1):25–34. https://doi.org/10.1016/j.beem.2012.11.002.; Хамани Н.М., Саидова Р.А., Хамани И.В. и др. Ретроспективный анализ факторов риска тромботических осложнений при приеме комбинированных оральных контрацептивов. Акушерство и гинекология. 2019;(6):108–14. https://doi.org/10.18565/aig.2019.6.108-114.; Макацария А.Д., Бицадзе В.О., Блинов Д.В. и др. Информация о комбинированных гормональных контрацептивных препаратах (КГК), содержащих комбинацию диеногест + этинилэстрадиол (лекарственный препарат Жанин). Акушерство, Гинекология и Репродукция. 2019;13(1):7–12. https://doi.org/10.17749/2313-7347.2019.13.1.007-012.; Манухин И.Б., Тумилович Л.Г., Геворкян М.А. Гинекологическая эндокринология. Клинические лекции: руководство для врачей. 3-е изд. М.: ГЭОТАР-Медиа, 2013. 272 с.; Венозный тромбоэмболизм и тромбоэмболия легочной артерии. Под ред. И.Н. Бокарева, Л.В. Поповой. 2-е изд. М.: МИА, 2013. 512 с.; Шабанова Н.А., Зайнулина М.С. Современные подходы к профилактике тромбоэмболических осложнений при беременности. Журнал акушерства и женских болезней. 2011;60(3):161–8.; Бокерия Л.А. Затевахин И.И., Кириенко А.И. и др. Российские клинические рекомендации по диагностике, лечению и профилактике венозных тромбоэмболических осложнений. Флебология. 2015;9(4–2):1–52.; Овчинников Ю.В., Панфилов Д.Н., Зеленов М.В. и др. Тромбоэмболия легочной артерии у женщин, принимающих пероральные гормональные контрацептивы. Клиническая медицина. 2015;93(10):58–66.; Бокарев И.Н., Люсов В.А, Кириенко А.И. и др. Венозные тромбозы и тромбоэмболия легочных артерий. Российский кардиологический журнал. 2011;90(4):5–12.; 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism. The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J. 2014;35(43):3033–80, 3069a–3069k. https://doi.org/10.1093/eurheartj/ehu283.; Беженарь В.Ф., Цвелев Ю.В., Левшанков А.И. и др. Тромбоэмболические осложнения в акушерско-гинекологической практике. Журнал акушерства и женских болезней. 2004;53(1):55–72.; Гордеев Н.А., Седов В.М., Баллюзек Ф.В. и др. Профилактика тромбоэмболии легочной артерии клипированием нижней полой и подвздошных вен: показания, техника, ближайшие и отдаленные результаты. Новости хирургии. 2010;18(4):157–64.; Карева Е.Н. Тромбозы и гестагены. Доктор. Ру. 2019;7(162):57–64. https://doi.org/10.31550/1727-2378-2019-162-7-57-64.; Шишкова В.Н. Подводные камни современной контрацепции: фокус на риск тромбозов и метаболические нарушения. Земский врач. 2012;(3):45–52.; Stocco B., Fumagalli H.F., Franceschini S.A. et al. Comparative study of the effects of combined oral contraceptives in hemostatic variables. An observational preliminary study. Medicine (Baltimore). 2015;94(4):e385. https://doi.org/10.1097/MD.0000000000000385.; Palacios S., Mejia A. Progestogen safety and tolerance in hormonal replacement therapy. Exp Opin Drug Safety. 2016;15(11):1515–25. https://doi.org/10.1080/14740338.2016.1223041.; Barsoum M.K., Heit J.A., Ashrani A.A. et al. Is progestin an independent risk factor for incident venous thromboembolism? A population-based case-control study. Thromb Res. 2010;126(5):373–8. https://doi.org/10.1016/j.thromres.2010.08.010.; Lidegaard O., Nielsen L.H., Skovlund C.W. et al. Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001–9. BMJ. 2011;343:d6423. https://doi.org/10.1136/bmj.d6423.; Lidegaard О. Severely biased review of studies assessing the risk of venous thrombosis in users of drospirenone-containing oral contraceptives. BJOG. 2018;125(8):929–31. https://doi.org/10.1111/14710528.15211.; https://www.gynecology.su/jour/article/view/1188

  8. 8
    Academic Journal

    المساهمون: This study was financially supported by the Ministry of Education and Training (MOET) of Vietnam under grant number B2018-MDA-03SP. The authors also thank the Center for Mining, Electro-Mechanical Research of Hanoi University of Mining and Geology (HUMG), Vietnam, the engineers and managers of the Coc Sau open-pit coal mine, Quang Ninh province, Vietnam for their help and cooperation., Данное исследование было финансово поддержано Министерством образования и профессиональной подготовки (MOET) Вьетнама в рамках гранта № B2018-MDA-03SP. Авторы также благодарят Центр горных и электромеханических исследований Ханойского университета горного дела и геологии (HUMG), Вьетнам, инженеров и руководителей угольного разреза Кок Сау, провинция Куангнинь, Вьетнам, за помощь и сотрудничество.

    المصدر: Gornye nauki i tekhnologii = Mining Science and Technology (Russia); Vol 7, No 2 (2022); 111-125 ; Горные науки и технологии; Vol 7, No 2 (2022); 111-125 ; 2500-0632

    وصف الملف: application/pdf

    Relation: https://mst.misis.ru/jour/article/view/347/287; https://mst.misis.ru/jour/article/view/347/288; Aneja V. P., Isherwood A., Morgan P. Characterization of particulate matter (PM10) related to surface coal mining operations in Appalachia. Atmospheric Environment. 2012;54:496–501. https://doi.org/10.1016/j.atmosenv.2012.02.063; Chakraborty M., Ahmad M., Singh R. et al. Determination of the emission rate from various opencast mining operations. Environmental Modelling & Software. 2002;17(5):467–480. https://doi.org/10.1016/S1364-8152(02)00010-5; Nie B.-S., Li X.-C., Yang T. et al. Distribution of PM2.5 dust during mining operation in coal workface. Journal of China Coal Society.2013;38(1):33–37. (In Chinese) URL: https://www.ingentaconnect.com/content/jccs/jccs/2013/00000038/00000001/art00006#; Kurth L. M., McCawley M., Hendryx M., Lusk S. Atmospheric particulate matter size distribution and concentration in West Virginia coal mining and non-mining areas. Journal of Exposure Science & Environmental Epidemiology. 2014;24:405–411. https://doi.org/10.1038/jes.2014.2; Li Z., Ma Z., van der Kuijp T. J. et al. A review of soil heavy metal pollution from mines in China: pollution and health risk assessment. Science of the Total Environment. 2014;468–469:843–853. https://doi.org/10.1016/j.scitotenv.2013.08.090; Dos Santos Pedroso-Fidelis G., Farias H. R., Mastella G. A. et al. Pulmonary oxidative stress in wild bats exposed to coal dust: A model to evaluate the impact of coal mining on health. Ecotoxicology and Environmental Safety. 2020;191:110211. https://doi.org/10.1016/j.ecoenv.2020.110211; Hendryx M., Islam M. S., Dong G.-H., Paul G. Air pollution emissions 2008–2018 from australian coal mining: implications for public and occupational health. International Journal of Environmental Research and Public Health. 2020;17(5):1570. https://doi.org/10.3390/ijerph17051570; Luo H., Zhou W., Jiskani I. M., Wang Z. Analyzing characteristics of particulate matter pollution in openpit coal mines: Implications for Green Mining. Energies. 2021;14(9):2680. https://doi.org/10.3390/en14092680; Moreno T., Trechera P., Querol X. et al. Trace element fractionation between PM10 and PM2.5 in coal mine dust: Implications for occupational respiratory health. International Journal of Coal Geology. 2019;203:52–59. https://doi.org/10.1016/j.coal.2019.01.006; Song Y., Wang X., Maher B. A. et al. The spatial-temporal characteristics and health impacts of ambient fine particulate matter in China. Journal of Cleaner Production. 2016;112:1312–1318. https://doi.org/10.1016/j.jclepro.2015.05.006; Alvarado M., Gonzalez F., Fletcher A., Doshi A. Towards the development of a low cost airborne sensing system to monitor dust particles after blasting at open-pit mine sites. Sensors. 2015;15(8):19667–19687. https://doi.org/10.3390/s150819667; Nambiar M. K., Robe F. R., Seguin A. M. et al. Diurnal and seasonal variation of area-fugitive methane advective flux from an open-pit mining facility in Northern Canada using WRF. Atmosphere. 2020;11(11):1227. https://doi.org/10.3390/atmos11111227; Trechera P., Moreno T., Córdoba P. et al. Comprehensive evaluation of potential coal mine dust emissions in an open-pit coal mine in Northwest China. International Journal of Coal Geology. 2021;235:103677. https://doi.org/10.1016/j.coal.2021.103677; Chaulya S. Assessment and management of air quality for an opencast coal mining area. Journal of Environmental Management. 2004;70(1):1–14. https://doi.org/10.1016/j.jenvman.2003.09.018; Patra A. K., Gautam S., Kumar P. Emissions and human health impact of particulate matter from surface mining operation – A review. Environmental Technology & Innovation. 2016;5:233–249. https://doi.org/10.1016/j.eti.2016.04.002; Alam G., Ihsanullah I., Naushad M., Sillanpää M. Applications of artificial intelligence in water treatment for optimization and automation of adsorption processes: recent advances and prospects. Chemical Engineering Journal. 2022;427:130011. https://doi.org/10.1016/j.cej.2021.130011; Li B.-H., Hou B.-C., Yu W.-T., Lu X.-B., Yang C.-W. Applications of artificial intelligence in intelligent manufacturing: a review. Frontiers of Information Technology & Electronic Engineering. 2017;18:86-96. https://doi.org/10.1631/FITEE.1601885; Nguyen H., Bui N. X., Tran H. Q., Le G. H. T. A novel soft computing model for predicting blast – induced ground vibration in open – pit mines using gene expression programming. Journal of Mining and Earth Sciences. 2020;61:107–116. (In Vietnamese) https://doi.org/10.46326/jmes.ktlt2020.09; Nguyen L. Q. A novel approach of determining the parameters of Asadi profiling function for predictiong ground subsidence due to inclied coal seam mining at Quang Ninh coal basin. Journal of Mining and Earth Sciences. 2020;61:86–95. (In Vietnamese) https://doi.org/10.46326/jmes.2020.61(2).10; Tayarani-N M.-H. Applications of artificial intelligence in battling against COVID-19: a literature review. Chaos, Solitons & Fractals. 2020;142:110338. https://doi.org/10.1016/j.chaos.2020.110338; Lal B., Tripathy S. S. Prediction of dust concentration in open cast coal mine using artificial neural network. Atmospheric Pollution Research. 2012;3(2):211–218. https://doi.org/10.5094/APR.2012.023; Bakhtavar E., Hosseini S., Hewage K., Sadiq R. Green blasting policy: simultaneous forecast of vertical and horizontal distribution of dust emissions using artificial causality-weighted neural network. Journal of Cleaner Production. 2021;283:124562. https://doi.org/10.1016/j.jclepro.2020.124562; Bui X.-N., Lee C. W., Nguyen H. et al. Estimating PM10 concentration from drilling operations in open-pit mines using an assembly of SVR and PSO. Applied Sciences. 2019;9(14):2806. https://doi.org/10.3390/app9142806; Li L., Zhang R., Sun J. et al. Monitoring and prediction of dust concentration in an open-pit mine using a deep-learning algorithm. Journal of Environmental Health Science and Engineering. 2021;19:401–414. https://doi.org/10.1007/s40201-021-00613-0; Lu X., Zhou W., Qi C. et al. Prediction into the future: A novel intelligent approach for PM2.5 forecasting in the ambient air of open-pit mining. Atmospheric Pollution Research. 2021;12(6):101084. https://doi.org/10.1016/j.apr.2021.101084; Gautam S., Prasad N., Patra A. K. et al. Characterization of PM2.5 generated from opencast coal mining operations: A case study of Sonepur Bazari Opencast Project of India. Environmental Technology & Innovation. 2016;6:1–10. https://doi.org/10.1016/j.eti.2016.05.003; Huang Y., Bao M., Xiao J. et al. Effects of PM2.5 on cardio-pulmonary function injury in open manganese mine workers. International Journal of Environmental Research and Public Health. 2019;16(11):2017. https://doi.org/10.3390/ijerph16112017; Wanjun T., Qingxiang C. Dust distribution in open-pit mines based on monitoring data and fluent simulation. Environmental Monitoring and Assessment. 2018;190:632. https://doi.org/10.1007/s10661-018-7004-9; Oguntoke O., Ojelede M.E., Annegarn H.J. Frequency of mine dust episodes and the influence of meteorological parameters on the Witwatersrand area, South Africa. International Journal of Atmospheric Sciences. 2013;2013:128463. https://doi.org/10.1155/2013/128463; Silvester S., Lowndes I., Hargreaves D. A computational study of particulate emissions from an open pit quarry under neutral atmospheric conditions. Atmospheric Environment. 2009;43(40):6415–6424. https://doi.org/10.1016/j.atmosenv.2009.07.006; Pao Y. Adaptive pattern recognition and neural networks. CWRU: Case Western Reserve University; 1989. https://doi.org/10.5860/choice.26-6311; Patra J. C., Pal R. N. A functional link artificial neural network for adaptive channel equalization. Signal Processing. 1995;43(2):181–195. https://doi.org/10.1016/0165-1684(94)00152-P; Nguyen T., Tran N., Nguyen B. M., Nguyen G. A resource usage prediction system using functional-link and genetic algorithm neural network for multivariate cloud metrics. In: 2018 IEEE 11th Conference on Service-Oriented Computing and Applications (SOCA). 2018. Pp. 49–56. https://doi.org/10.1109/SOCA.2018.00014; Majhi B., Naidu D. Pan evaporation modeling in different agroclimatic zones using functional link artificial neural network. Information Processing in Agriculture. 2021;8(1):134–147. https://doi.org/10.1016/j.inpa.2020.02.007; Nguyen T., Nguyen B. M., Nguyen G. Building Resource Auto-scaler with Functional-Link Neural Network and Adaptive Bacterial Foraging Optimization. In: Gopal TV, Watada J (eds.) Theory and Applications of Models of Computation. TAMC 2019. Lecture Notes in Computer Science. Springer, Cham. 2019. Pp. 501–517. https://doi.org/10.1007/978-3-030-14812-6_31; Kaveh A. Advances in metaheuristic algorithms for optimal design of structures. Springer, Cham; 2014. https://doi.org/10.1007/978-3-319-05549-7; Ting T., Yang X.-S., Cheng S., Huang K. Hybrid metaheuristic algorithms: past, present, and future. In: Yang X. S. (ed.) Recent Advances in Swarm Intelligence and Evolutionary Computation. Studies in Computational Intelligence. Springer, Cham; 2015. Pp. 71–83. https://doi.org/10.1007/978-3-319-13826-8_4; Yang Y., Chen H., Heidari A. A., Gandomi A. H. Hunger games search: Visions, conception, implementation, deep analysis, perspectives, and towards performance shifts. Expert Systems with Applications. 2021;177:114864. https://doi.org/10.1016/j.eswa.2021.114864; Chen W., Sarir P., Bui X.-N. et al. Neuro-genetic, neuro-imperialism and genetic programing models in predicting ultimate bearing capacity of pile. Engineering with Computers. 2020;36:1101–1115. https://doi.org/10.1007/s00366-019-00752-x; Erkoc M. E., Karaboga N. A novel sparse reconstruction method based on multi-objective Artificial Bee Colony algorithm. Signal Processing. 2021;189:108283. https://doi.org/10.1016/j.sigpro.2021.108283; Fang Q., Nguyen H., Bui X.-N., Tran Q.-H. Estimation of blast-induced air overpressure in quarry mines using cubist-based genetic algorithm. Natural Resources Research. 2020;29:593–607. https://doi.org/10.1007/s11053-019-09575-5; Liu L., Moayedi H., Rashid A. S. A. et al. Optimizing an ANN model with genetic algorithm (GA) predicting load-settlement behaviours of eco-friendly raft-pile foundation (ERP) system. Engineering with Computers. 2020;36:421–433. https://doi.org/10.1007/s00366-019-00767-4; Nguyen H., Bui H.-B., Bui X.-N. Rapid determination of gross calorific value of coal using artificial neural network and particle swarm optimization. Natural Resources Research. 2021;30:621–638. https://doi.org/10.1007/s11053-020-09727-y; Peng B., Wu L., Wang Y., Wu Q. Solving maximum quasi-clique problem by a hybrid artificial bee colony approach. Information Sciences. 2021;578:214–235. https://doi.org/10.1016/j.ins.2021.06.094; Xu Y., Wang X. An artificial bee colony algorithm for scheduling call centres with weekend-off fairness. Applied Soft Computing. 2021;109:107542. https://doi.org/10.1016/j.asoc.2021.107542; Zhang X., Nguyen H., Bui X.-N. et al. Evaluating and predicting the stability of roadways in tunnelling and underground space using artificial neural network-based particle swarm optimization. Tunnelling and Underground Space Technology. 2020;103:103517. https://doi.org/10.1016/j.tust.2020.103517; Zhang X., Nguyen H., Bui X.-N. et al. Novel soft computing model for predicting blast-induced ground vibration in open-pit mines based on particle swarm optimization and XGBoost. Natural Resources Research. 2020;29:711–721. https://doi.org/10.1007/s11053-019-09492-7; Akay B., Karaboga D., Gorkemli B., Kaya E. A survey on the artificial bee colony algorithm variants for binary, integer and mixed integer programming problems. Applied Soft Computing. 2021;106:107351. https://doi.org/10.1016/j.asoc.2021.107351; Aygun H., Turan O. Application of genetic algorithm in exergy and sustainability: A case of aero-gas turbine engine at cruise phase. Energy. 2022;238:121644. https://doi.org/10.1016/j.energy.2021.121644; Bai B., Zhang J., Wu X. et al. Reliability prediction-based improved dynamic weight particle swarm optimization and back propagation neural network in engineering systems. Expert Systems with Applications. 2021;177:114952. https://doi.org/10.1016/j.eswa.2021.114952; Kennedy J., Eberhart R. Particle swarm optimization. In: Proceedings of ICNN’95 – International Conference on Neural Networks. 1995. Pp. 1942–1948. https://doi.org/10.1109/ICNN.1995.488968; Kiran M. S., Hakli H., Gunduz M., Uguz H. Artificial bee colony algorithm with variable search strategy for continuous optimization. Information Sciences. 2015;300:140–157. https://doi.org/10.1016/j.ins.2014.12.043; Liang B., Zhao Y., Li Y. A hybrid particle swarm optimization with crisscross learning strategy. Engineering Applications of Artificial Intelligence. 2021;105:104418. https://doi.org/10.1016/j.engappai.2021.104418; Mirjalili S. Genetic algorithm. In: Evolutionary Algorithms and Neural Networks. Studies in Computational Intelligence. Springer, Cham; 2019. Pp. 43–55. https://doi.org/10.1007/978-3-319-93025-1_4; Pourzangbar A., Vaezi M. Optimal design of brace-viscous damper and pendulum tuned mass damper using Particle Swarm Optimization. Applied Ocean Research. 2021;112:102706. https://doi.org/10.1016/j.apor.2021.102706; Roy A., Dubey C. P., Prasad M. Gravity inversion of basement relief using Particle Swarm Optimization by automated parameter selection of Fourier coefficients. Computers & Geosciences. 2021;156:104875. https://doi.org/10.1016/j.cageo.2021.104875; Tapia A. R., del Nozal A., Reina D. G., Millán P. Three-dimensional optimization of penstock layouts for micro-hydropower plants using genetic algorithms. Applied Energy. 2021;301:117499. https://doi.org/10.1016/j.apenergy.2021.117499; Wang C., Guo C., Zuo X. Solving multi-depot electric vehicle scheduling problem by column generation and genetic algorithm. Applied Soft Computing. 2021;112:107774. https://doi.org/10.1016/j.asoc.2021.107774; Wang S.-C. Genetic algorithm. In: Interdisciplinary Computing in Java Programming. The Springer International Series in Engineering and Computer Science. Springer, Boston; 2003. Pp. 101–116. https://doi.org/10.1007/978-1-4615-0377-4_6; Xiang W.-L., Li Y.-Z., He R.-C., An M.-Q. Artificial bee colony algorithm with a pure crossover operation for binary optimization. Computers & Industrial Engineering. 2021;152:107011. https://doi.org/10.1016/j.cie.2020.107011; https://mst.misis.ru/jour/article/view/347

  9. 9
    Academic Journal

    المصدر: Arkheologiia Evraziiskikh Stepei (Archaeology of the Eurasian Steppes); No. 3 (2022); 132-137 ; Археология Евразийских степей; № 3 (2022); 132-137 ; 2618-9488 ; 2587-6112 ; 10.24852/10.24852/2587-6112.2022.3

    وصف الملف: application/pdf

  10. 10
    Academic Journal
  11. 11
    Academic Journal
  12. 12
    Academic Journal

    المصدر: Obstetrics, Gynecology and Reproduction; Vol 15, No 2 (2021); 173-181 ; Акушерство, Гинекология и Репродукция; Vol 15, No 2 (2021); 173-181 ; 2500-3194 ; 2313-7347

    وصف الملف: application/pdf

    Relation: https://www.gynecology.su/jour/article/view/971/904; Arnett D.K., Blumenthal R.S., Albert M.A. et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease. Circulation. 2019;140(11):е596–е646. https://doi.org/10.1161/CIR0000000000000678.; Denorme F., Kraft P., Pareyn I. et al. Reduced ADAMTS13 levels in patients with acute and chronic cerebrovascular disease. PLoS One. 2017;12(6):e0179258. https://doi.org/10.1371/journal.pone.0179258.; Карахалис Л.Ю. Персонифицированный выбор гормональной контрацепции. Гинекология. 2018;20(4):52–4. https://doi.org/10.26442/2079-5696_2018.4.52-54.; Муминoвa М.С. Тpoмбoэмбoличeскиe oслoжнeния пpи пpимeнeнии кoмбиниpoвaнных opaльных кoнтpaцeптивoв. Aллeя нaуки. 2018;8(11):96–100.; Lloyd-Jones D.M., Hong Y., Labarthe D. et al. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association’s Strategic Impact Goal through 2020 and beyond. Circulation. 2010;121(4):586–61. https://doi.org/10.1161/CIRCULATIONAHA.109.192703.; Кузнeцoвa И.В., Сухaнoвa Г.A. Кoнтpaцeпция и pиск apтepиaльнoгo тpoмбoзa. PМЖ. Мaть и Дитя. 2013;21(23):1128–33.; Блинов Д.В., Ушакова Т.И., Макацария Н.А. и др. Гормональная контрацепция и дефицит магния: результаты субанализа исследования MAGYN. Акушерство, Гинекология и Репродукция. 2017;11(1):36– 48. https://doi.org/10.17749/2313-7347.2017.11.1.036-048.; Макацария А.Д., Дадак К., Бицадзе В.О. и др. Результаты второй волны исследования профиля пациенток с гормонально-зависимыми состояниями и дефицитом магния. Акушерство и гинекология. 2017;(5):124–31. https://doi.org/10.18565/aig.2017.5.124-31.; Мeдицинскиe кpитepии пpиeмлeмoсти для испoльзoвaния мeтoдoв кoнтpaцeпции. 5-e изд. Жeнeвa: ВOЗ, 2015. 192 с. Peжим дoступa: http://www.euro.who.int/data/assets/pdf_file/0005/348116/MEC-merged.pdf.; Карахалис Л.Ю., Папова Н.С., Майорова А.В. Лечение генитального эндометриоза гормональными контрацептивами. Медицинский совет. 2016;(2):6–11. https://doi.org/10.21518/2079-701X-2016-2-6-11.; Карахалис Л.Ю., Федорович О.К. Дифференцированное применение комбинированных пероральных контрацептивов. Акушерство и гинекология. 2006;(6):51–4.; Benjamin E.J., Muntner Р., Alonso А. et al. Heart disease and stroke statistics – 2019 Update: a report from the American Heart Association. Circulation. 2019;139(10):e56–e528. https://doi.org/10.1161/CIR.0000000000000659.; Champaloux S.W., Tepper N.K., Monsour M. et al. Use of combined hormonal contraceptives among women with migraines and risk of ischemic stroke. Am J Obstet Gynecol. 2017;16(5):489.e1–489.e7. https://doi.org/10.1016/j.ajog.2016.12.019.; Fraser A., Catov J.M., Lawlor D.A., Rich-Edwards J.W. Pregnancy characteristics and women’s cardiovascular health. In: Handbook of life course health development. Springer International Publishing, 2018. 145–65. https://doi.org/10.1007/978-3-319-47143-3_8.; Proia K.K., Thota A.B., Njie G.J. et al. Team-based care and improved blood pressure control: a community guide systematic review. Am J Prev Med. 2014;47(1):86–99. https://doi.org/10.1016/j.amepre.2014.03.004.; Baart S.J., Dam V., Scheres L.J.J., et al., CREW consortium. Cardiovascular risk prediction models for women in the general population: A systematic review. PLoS One. 2019;14:e0210329. https://doi.org/10.1371/journal.pone.0210329 pmid:30620772.; Belbasis L., Savvidou M.D., Kanu C. et al. Birth weight in relation to health and disease in later life: an umbrella review of systematic reviews and meta-analyses. BMC Med. 2016;14(1):147. https://doi.org/10.1186/s12916-016-0692-5 pmid:27677312.; Carlton C., Banks M., Sundararajan S. Oral contraceptives and ischemic stroke risk. Stroke. 2018;49(4):e157–e159. https://doi.org/10.1161/STROKEAHA.117.020084.; Kaminski P., Szpotanska-Sikorska M., Wielgos M. Cardiovascular risk and the use of oral contraceptives. Neuro Endocrinol Lett. 2013;34(7):587–9.; Xu X., Li J., Sheng W., Liu L. Meta-analysis of genetic studies from journals published in China of ischemic stroke in the Han Chinese population. Cerebrovasc Dis. 2008;26:48–62. https://doi.org/10.1159/000135653.; Li F., Zhu L., Zhang J. et al. Oral contraceptive use and increased risk of stroke: A dose-response meta-analysis of observational studies. Front Neurol. 2019;(10):993. https://doi.org/10.3389/fneur.2019.00993.; Isiadinso I., Wenger N.K. Do we need a different approach to assess cardiovascular risk in women? US Cardiol Rev. 2017;11(1):5. https://doi.org/10.15420/usc.2016:8:2.; Tanz L.J., Stuart J.J., Williams P.L. et al. Preterm delivery and maternal cardiovascular disease in young and middle-aged adult women. Circulation. 2017;135(6):578–89. https://doi.org/10.1161/CIRCULATIONAHA.116.025954.; Бaяндуpян Э.A., Сaмбуpoвa Н.В., Aничкoвa E.В. и дp. Этиoпaтoгeнeтичeскиe фaктopы pискa paзвития инсультa у бepeмeнных. Aкушepствo, Гинeкoлoгия и Рeпpoдукция. 2019;13(3):217–26. https://doi.org/10.17749/2313-7347.2019.13.3.217-226.; Pezzini A., Grassi M., Iacoviello L. et al. Inherited thrombophilia and stratification of ischaemic stroke risk among users of oral contraceptives. J Neurol Neurosurg Psychiatry. 2007;78(3):271–6. https://doi.org/10.1136/ jnnp.2006.101675.; Мeжeвитинoвa E.A., Хaмoшинa М.Б., Pуднeвa O.Д. и дp. Гopмoнaльнaя кoнтpaцeпция у жeнщин высoкoгo pискa: пути peшeния пpoблeмы. Дoктop.Pу. 2012;(1):27–33.; Wiesel M.L., Borg J.Y., Grunebaum L. et al. Influence of protein S deficiency on the arterial thrombosis risk. Presse Med. 1991;20(22):1023–7.; Douay X., Lucas C., Caron C. et al. Antithrombin, protein C and protein S levels in 127 consecutive young adults with ischemic stroke. Acta Neurol Scand. 1998;98(2):124–7.; Moster M. Coagulopathies and arterial stroke. J Neuroophthalmol. 2003;23(1):63–71. https://doi.org/10.1097/00041327-200303000-00012.; Smith F.B., Lee A.J., Fowkes F.G. et al. Hemostatic factors as predictors of ischemic heart disease and stroke in the Edinburgh Artery Study. Arterioscler Thromb Vasc Biol. 1997;17(11):3321–5. https://doi.org/10.1161/01.ATV.17.11.3321.; Сукoнцeвa Т.A., Кaплинa O.Ю. К вoпpoсу o пaтoгeнeзe тpoмбoзoв пpи aнтифoсфoлипиднoм синдpoмe. Aкушepствo, Гинeкoлoгия и Рeпpoдукция. 2018;12(3):72–8. https://doi.org/10.17749/23137347.2018.12.3.072-078.; Urbanus R.T. Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study. Lancet Neurol. 2009;11(8):998–1005. https://doi.org/10.1016/S1474-4422(09)70239-X.; https://www.gynecology.su/jour/article/view/971

  13. 13
    Academic Journal

    المصدر: Obstetrics, Gynecology and Reproduction; Vol 15, No 2 (2021); 143-155 ; Акушерство, Гинекология и Репродукция; Vol 15, No 2 (2021); 143-155 ; 2500-3194 ; 2313-7347

    وصف الملف: application/pdf

    Relation: https://www.gynecology.su/jour/article/view/968/901; Arnett D.K., Blumenthal R.S., Albert M.A. et al. 2019 ACC/AHA Guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;140(11):e596–e646. https://doi.org/10.1161/CIR.0000000000000678.; Champaloux S.W., Tepper N.K., Monsour M. et al. Use of combined hormonal contraceptives among women with migraines and risk of ischemic stroke. Am J Obstet Gynecol. 2017;16(5):489.e1–489.e7. https://doi.org/10.1016/j.ajog.2016.12.019.; Denorme F., Kraft P., Pareyn I. et al. Reduced ADAMTS13 levels in patients with acute and chronic cerebrovascular disease. PLoS One. 2017;12(6):e0179258. https://doi.org/10.1371/journal.pone.0179258.; Dhont М. History of oral hormonal contraception. Eur J Contracept Reprod Health Care. 2010;15(Suppl 2):S12–8. https://doi.org/10.3109/13625187.2010.513071.; Hugon-Rodin J., Horellou M., Conard J. et al. Combined hormonal contraceptives and first venous thrombosis in young french women: impact of thrombotic family history. J Endocr Soc. 2017;1(6):762–71. https://doi.org/10.1210/js.2017-00090.; Isiadinso I, Wenger NK. Do we need a different approach to assess cardiovascular risk in women? US Cardiol Rev. 2017;11:5–9. https://doi.org/10.15420/usc.2016:8:2.; Lidegaard Ø., Edström B., Kreiner S. Oral contraceptives and venous thromboembolism: a five-year national case-control study. Contraception. 2002;65(3):187–96. https://doi.org/10.1016/s0010-7824(98)00033-x.; Карахалис Л.Ю., Федорович О.К. Дифференцированное применение комбинированных пероральных контрацептивов. Акушерство и гинекология. 2006;(6):51–4.; Макацария А.Д., Дадак К., Бицадзе В.О. и др. Клинические особенности у пациенток с гормонально-зависимыми состояниями и дефицитом магния. Акушерство и гинекология. 2017;(5):124–31. https://doi.org/10.18565/aig.2017.5.124-131.; Trenor C.C., Chung R.J., Michelson A.D. et al. Hormonal contraception and thrombotic risk: a multidisciplinary approach. Pediatrics. 2011;127(2):347–57. https://doi.org/10.1542/peds.2010-2221.; Карахалис Л.Ю. Персонифицированный выбор гормональной контрацепции. Гинекология. 2018;20(4):52–4. https://doi.org/10.26442/20795696_2018.4.52-54.; Карахалис Л.Ю., Папова Н.С., Майорова А.В. Лечение генитального эндометриоза гормональными контрацептивами. Медицинский совет. 2016;(2):6–11. https://doi.org/10.21518/2079-701X-2016-2-6-11.; Макацария А.Д., Бицадзе В.О., Акиньшина С.В. Тромбозы и тромбоэмболии в акушерско-гинекологической клинике. M.: МИА, 2007. 1064 с.; Baart S.J., Dam V., Scheres L.J.J. et al.; CREW consortium. Cardiovascular risk prediction models for women in the general population: A systematic review. PLoS One. 2019;14(1):e0210329. https://doi.org/10.1371/journal.pone.0210329.; Lloyd-Jones D.M., Hong Y., Labarthe D. et al. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association’s Strategic Impact Goal through 2020 and beyond. Circulation. 2010;121(4):586–61. https://doi.org/10.1161/CIRCULATIONAHA.109.192703.; Carlton C., Banks M., Sundararajan S. Oral contraceptives and ischemic stroke risk. Stroke. 2018;49(4):e157–e159. https://doi.org/10.1161/STROKEAHA.117.020084; Блинов Д.В., Ушакова Т.И., Макацария А.Д. и др. Гормональная конфацепция и дефицит магния: результаты субанализа исследования MAGYN. Акушерство, Гинекология и Репродукция. 2017;11(1):36– 48. https://doi.org/10.17749/2313-7347.2017.11.1.036-048.; Gourdy P., Bachelot A., Catteau-Jonard S. et al. Hormonal contraception in women at risk of vascular and metabolic disorders: guidelines of the French Society of Endocrinology. Ann Endocrinol (Paris). 2012;73(5):469–87. https://doi.org/10.1016/j.ando.2012.09.001.; Belbasis L., Savvidou M.D., Kanu C. et al. Birth weight in relation to health and disease in later life: an umbrella review of systematic reviews and meta-analyses. BMC Med. 2016;14(1):147. https://doi.org/10.1186/s12916-016-0692-5.; Timmis A., Townsend N., Gale C.P. et al.; European Society of Cardiology. European Society of Cardiology: Cardiovascular Disease Statistics 2019. Eur Heart J. 2020;41(1):12–85. https://doi.org/10.1093/eurheartj/ehz859.; Сукoнцeвa Т.A., Кaплинa O.Ю. К вoпpoсу o пaтoгeнeзe тpoмбoзoв пpи aнтифoсфoлипиднoм синдpoмe. Aкушepствo, Гинекология и Репродукция. 2018;12(3):72–8. https://doi.org/10.17749/2313-7347.2018.12.3.072-078.; Макацария А.Д., Саидова Р.А. Гормональная контрацепция и тромбофилические состояния. M.: Триада-Х, 2004. 240 с.; Rott H. Birth control pills and thrombotic risks: differences of contraception methods with and without estrogen. Hamostaseologie 2019;39(1):42–8. https://doi.org/10.1055/s-0039-1677806.; Proia K.K., Thota A.B., Njie G.J. et al. Team-based care and improved blood pressure control: a community guide systematic review. Am J Prev Med. 2014;47:86–99. https://doi.org/10.1016/j.amepre.2014.03.004.; Хамани Н.М., Саидова Р.А., Хамани И.В. и др. Ретроспективный анализ факторов риска тромботических осложнений при приеме комбинированных оральных контрацептивов. Акушерство и гинекология. 2019;(6):108–14. https://doi.org/10.18565/aig.2019.6.108-114.; Мeдицинскиe кpитepии пpиeмлeмoсти для испoльзoвaния мeтoдoв кoнтpaцeпции. 5-e изд. Жeнeвa: ВOЗ, 2015. 192 с. Peжим дoступa: http://www.euro.who.int/data/assets/pdf_file/0005/348116/MEC-merged.pdf.; Тромбогеморрагические осложнения в акушерско-гинекологической практике. Руководство для врачей. Под ред. А.Д. Макарация. M.: МИА, 2011. 1050 с.; https://www.gynecology.su/jour/article/view/968

  14. 14
  15. 15
    Academic Journal
  16. 16
    Academic Journal

    المصدر: Meditsinskiy sovet = Medical Council; № 12 (2018); 146-151 ; Медицинский Совет; № 12 (2018); 146-151 ; 2658-5790 ; 2079-701X ; 10.21518/2079-701X-2018-12

    وصف الملف: application/pdf

    Relation: https://www.med-sovet.pro/jour/article/view/2579/2548; Alkema L, Kantorova V, Menozzi C, Biddlecom A. National, regional and global rates and trends in contraceptive prevalence and unmet need for family planning between 1990 and 2015: a systematic and comprehensive analysis. Lancet, 2013, 381(9878): 1642-1652.; Daniels K, Daugherty J, Jones J. Current contraceptive status among women aged 15–44: United States, 2011–2013. NCHS Data Brief 2014, 173: 1-8.; Hannaford PC, Iversen L, Macfariane TV, et al. Mortality among contraceptive pill users: cohort evidence from Royal College of General Practitioners’ Oral Contraception Study. BMJ, 2010, 340: 927.; Sedgh G, Singh S, Hussain R. Intended and unintended pregnancies worldwide in 2012 and recent trends. Stud Fam Plann, 2014, 45(3): 301–314.; Bank J, Yun SC, Kim YM, Khang YH. Impact of unintended pregnancy on maternal mental health: a causal analysis using follow up data of the Panel Study on Korean Children (PSKC). BMC Pregnancy Childbirth, 2015, 15: 85.; Tsui Amy O, McDonald-Mosley R, Burke AE. Family planning and the burden on unintended pregnancies. Epidemiol Rev, 2010, 32(1): 152-174.; De La Rocherbrochard E, Joshi H. Children born after unplanned pregnancies and cognitive development at 3 years: social differentials in the United Kingdom Millenium Cohort. Am J Epidemiol, 2013, 178(6): 910–920.; Kadir R, James AH. Reproductive health in women with bleeding disorders. Canada: World Federation of Hemophilia, 2009, 15 p.; Национальные медицинские критерии приемлемости методов контрацепции. М., 2012, 16 с.; Lidegaard O, Lokkegaard E, Svendsen AL, Agger C. Hormonal contraception and risk of venous thromboembolism: national follow-up study. BMJ, 2009, 339: b2890.; Previtali E, Bucciarelli P, Passamonti SM, Martinelli I. Risk factors for venous and arterial thrombosis. Blood Transfus, 2011, 9: 120–138.; Curtis S, Evens E, Sambisa W. Contraceptive discontinuation and unintended pregnancy: an imperfect relationship. Int Perspect Sex Reprod Health, 2011, 37(2): 58–66.; Trussell J. Contraceptive failure in the Unated States. Contraception, 2011, 83(5): 397–404.; Дикке Г.Б., Ерофеева Л.В. Контрацепция в современной России: применение и информированность (популяционное исследование). Акушерство и гинекология, 2016, 2: 105–110.; Денисов Б.П. Применение контрацепции в России (по материалам выборочного обследования). Доказательная медицина и клиническая эпидемиология, 2009, 1: 34–39.; Lindh I, Blohm F, Andersson-Ellströ m E, et al. Contraceptive use and pregnancy outcome in three generations of Swedish female teenagers from the same urban population. Contraception, 2009, 80: 163–169.; Lawrie TA, Helmerhorst FM, Maitra NK, et al. Types of progestogens in combined oral contraception: effectiveness and side-effects. Cochrane Database Syst Rev, 2011, 11: CD004861.; Dinger JC, Bardenheuer K, Assmann A. International Active Surveillance Study of Women Taking Oral Contraceptives (INAS-OC Study). BMC Med Res Methodol, 2009, 9: 77.; Veljković M, Veljković S. The risk of breast, cervical, endometrial and ovarian cancer in oral contraceptive users. Med Pregl, 2010, 63(9–10): 657– 661.; Dossus L, Allen N, Kaaks R, et al. Reproductive risk factors and endometrial cancer: the European Prospective Investigation into Cancer and Nutrition. Int J Cancer, 2010, 127(2): 442–451.; Vessey M, Yeates D, Flynn S. Factors affecting mortality in a large cohort study with special reference to oral contraceptive use. Contraception, 2010, 82(3): 221–229.; Moorman PG, Havrilesky LJ, Gierisch JM, et al. Oral contraceptives and risk of ovarian cancer and breast cancer among high-risk women: a systematic review and meta-analysis. J Clin Oncol, 2013, 31: 4188–4198.; Havrilesky LJ, Gierisch JM, Moorman PG, et al. Oral contraceptive use for the primary prevention of ovarian cancer. Evid Rep Technol Assess (Full Rep), 2013, 212: 514.; Beral V, Doll R, Hermon C, Peto R, Reeves G. Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls. Lancet, 2008, 371: 303–314.; Havrilesky LJ, Moorman PG, Lowery WJ, et al. Oral contraceptive pills as primary prevention for ovarian cancer: a systematic review and meta-analysis. Obstet Gynecol, 2013, 122: 139–147.; Sitruk-Ware R, Nath A, Mishell DR. Contraception technology: past, present and future. Contraception, 2013, 87(3): 319–330.; Bonafede MM, Miller JD, Lukes AS et al. Retrospective database analysis of clinical outcomes and costs for treatment of abnormal uterine bleeding among women enrolled in US Medicaid programs. Clinin Econom Outcom Res, 2014, 6: 423–429.; ACOG Practice Bulletin No. 136: Management of Abnormal Uterine Bleeding Associated With Ovulatory Dysfunction. Obstet Gynecol, 2013, 122: 176-185.; ACOG. Management of acute abnormal uterine bleeding in non-pregnant women. Committee Opinion № 557. Obstet Gynecol, 2013, 121: 891-896.; Munro MG, et al, for the FIGO Working Group on Menstrual Disorders. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. Intern J Gynecol Obstet, 2011, 113: 3–13.; SOGC. Abnormal Uterine Bleeding in Pre-Menopausal Women. J Obstet Gynaecol Can, 2013, 35(5 Suppl 1): 1-28.; Chandra V, Kim JJ, Benbrook DM, Dwivedi A, Rai R. Therapeutic options for management of endome-trial hyperplasia. J Gynecol Oncol, 2016, 27(1): e8.; Berenson AB, van den Berg P, Williams KJ, Rahman M. Effect of injectable and oral contraceptives on glucose and insulin levels. Obstet Gynecol, 2011, 117(1): 41–47.; Weill A, Dalichampt M, Raguideau F, Ricordeau Ph, et al. Low dose oestrogen combined oral contraception and risk of pulmonary embolism, stroke, and myocardial infarction in five million French women: cohort study. BMJ, 2016, 353: i2002.; Mayeda ER, Torgal AH, Westhoff CL. Weight and Body Composition Changes During Oral Contraceptive Use in Obese and Normal Weight Women. J Womens Health (Larchmt), 2014, 23(1): 38–43.; Blum RW, Astone NM, Decker MR, et al. A conceptual framework for early adolescence: A platform for research. Int J Adolesc Med Health, 2014, 26: 321e31.; Rothman KJ, Wise LA, Sørensen HT, Riis AH, Mikkelsen EM, Hatch EE. Volitional Determinants and Age-related Decline in Fecundability: A General Population Prospective Cohort Study in Denmark. Fertil Steril, 2013, 99(7): 1958–1964.; Holinka CF, Brincat M, Coelingh Bennink HJT. Preventive effect of oral estetrol in a menopausal hot flash model. Climacteric, 2008, 11(Suppl 1): 15–21.; Coelingh Bennink HJT, Heegaard A-M, Visser M, Holinka CF, Christiansen C. Oral bioavailability and bone-sparing effects of estetrol in an osteoporosis model. Climacteric, 2008, 11(Suppl 1): 2–14.; Kannis JA, Adams J, Borgström F, et al. The cost-effectiveness of alendronate in the management of osteoporosis. Bone, 2008, 42(1): 4–15.; Allali F, Mansouri L, Abourazzak F, et al. The effect of past use of oral contraceptive on bone mineral density, bone biochemical markers and muscle strength in healthy pre and post menopausal women. BMC Women’s Health, 2009, 9: 31.; Allen RH, Cwiak CA. Contraception for midlife women. Menopause, 2016, 23(1): 183–191.; Schindler AE. Non-contraceptive benefits of oral hormonal contraceptives. Int J Endocrinol Metab, 2013, 11(1): 41-47.; Кузнецова И.В. Персональный подбор гормональной контрацепции. Гинекология, 2017, 19(2): 36–44.; https://www.med-sovet.pro/jour/article/view/2579

  17. 17
    Academic Journal
  18. 18
    Academic Journal
  19. 19
    Academic Journal
  20. 20
    Academic Journal